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Dr David Sugarbaker (Boston, Mass). This study represents
the first comprehensive evaluation of patients at a relatively long
term after pneumonectomy. It demonstrates clearly that pneumo-
nectomy can be a lifesaving procedure and that these patients
can enjoy relatively normal physiology and presumably quality
of life at a significant time period after resection.
This study attempts to evaluate several factors that are impor-
tant in producing long-term cardiopulmonary function. I’d like
to congratulate Dr Deslauriers and his group on completing a study
that I think is long overdue. These results are interesting and may
have a significant impact on the selection and evaluation of pa-
tients who are considered for pneumonectomy for a variety of rea-
sons, and here for oncologic reasons.
I have3questions. First, in light of your finding that compensatory
hyperinflation is present and that it has potential beneficial effects in
the patient postpneumonectomy—and I think that’s certainly my
clinical intuition, that seeing patients doing well with a significant
mediastinal shift, those 2 often go together, as long as there is not ob-
struction of the airway and this physiologic compensation is benefi-
cial—given this finding that you have clearly demonstrated, can you
comment on the conventional use of preoperative quantitative V/Q
scanning to predict postoperative FEV1, particularly in light of this
confounding hyperinflation and your data that showed only a 15%
to 30% overall reduction in FEV1?
Dr Deslauriers. Preoperative V/Q scans are useful to predict
short-term post-resectional function but are probably less reliable
to predict long-term function because late physiologic adjust-
ments, such as hyperinflation, mediastinal shift, and diaphragmatic
function, are not taken into account by these scans.
Dr Sugarbaker. I think your study shows that the human phys-
iology is amazingly compensatory and that quantitative V/Q scans
may not have all the answers.
Number 2, what impact do you think this study has on the con-
ventional criteria for patient selection, which were obviously used
in this group. I presume the initial criteria were conventional, and
do you think this study will have any impact on what we should
evaluate before contemplating pneumonectomy?
DrDeslauriers.Although pneumonectomies carry a significant
risk of operative mortality, the fact that most survivors are able to
successfully adjust to living with only 1 lung is remarkable. I am
not sure, however, that these results will change our selection cri-
teria, but they will certainly provide reasonable answers to patients
who are anxious about quality of life, exercise tolerance, and level
of dyspnea after this operation.14 The Journal of Thoracic and Cardiovascular SurgeDr Sugarbaker. I have a final question. This study was able to
find 117 patients living at least 5 years from an initial cohort of 523
patients whom you nicely outlined. I think if you corrected it for
the patients in stage II and III whom you presented, the survival
would be well below 20% 5-year survival. In light of that, could
you address the observation that these results in terms of function-
ality may not be applicable to the patients who lived 2 or 3 years?
Also, I would say that the survival here is sort of approaching that
for extrapleural pneumonectomy and meso, which is approxi-
mately 15% to 20% at 5 years, and you just wonder whether the
earlier physiology has self-selected those patients out of this and
they have died beforehand, although you point out that 5% of
deaths were cardiac.
DrDeslauriers.The overall 5-year survival for the entire cohort
of 523 patients was 31.4% and 81% of patients included in this
study had stage 2 and 3 disease. When we carefully analyze the
cause of death of the 406 patients who died during the interval, it
was interesting to note that the majority had cancer-related deaths
sometimes more than 5 years after the operation and that few died
of respiratory failure. This information certainly suggests that the
results of this study would be applicable to patients who live for
only 2 to 3 years postoperatively as long as they are free of disease.
Dr Sugarbaker. This is an excellent study, Dr Deslauriers. Your
group is to be congratulated.
Dr Dominique Grunenwald (Paris, France). I congratulate
you, Jean, for rehabilitating pneumonectomy after spending years
defending sleeve lobectomies to precisely avoid pneumonectomy.
Nevertheless, it was an excellent article. In my opinion, it is
encouraging, this 30% loss of respiratory function, to open the
way for proposing surgical resections for the second primaries,
metachronous disease, in a residual lung in the long term after
a pneumonectomy.
My question is, did you look at the difference between the left
and the right side because of the difference of volumes of the
lungs?
DrDeslauriers.We did look at respiratory function after left and
right pneumonectomies, and other than for losses in expiratory vol-
umes, which were higher after right pneumonectomy than after left,
there were no significant differences in all other parameters of lung
function whether the patient had a right or left pneumonectomy.
Dr Federico Venuta (Rome, Italy). This is a large number of
patients. Were you able to stratify the cardiac performance of these
patients according to the FEV1? Our experience is that the pneu-
monectomy population overall has good results in terms of heart
function, but if you go down with the FEV1, in the long run, at least
in our experience, they develop a significant degree of pulmonary
hypertension and heart failure, and after 5 years, most of the pa-
tients with lower values of FEV1 are in this category.
Dr Deslauriers.Youmean correlate FEV1 with the level of pul-
monary hypertension.
Dr Venuta. Yes. It was high. It was approximately 90%. It was
87%, the preoperative FEV1.
Dr Deslauriers. In this series, there were no significant differ-
ences in pulmonary function (FEV1), DLCO, PAO2, and 6-minute
walk distance, whether the patient had pulmonary hypertension
or not.
Dr Paul Van Schil (Antwerp, Belgium). I would like to come
back to the drainage of the pneumonectomy space. I rememberry c January 2011
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pneumonectomy drainage system, the incidence of postpneumo-
nectomy acute respiratory distress syndrome decreases. What is
your current policy and could this influence the long-term results
regarding respiratory function?
Dr Deslauriers. Since we looked at this problem some years
ago and determined that water seal drainage of the pneumonec-
tomy space was a risk factor for postpneumonectomy edema
caused by rapid overdistention of the remaining lung, I do not drain
the pneumonectomy space. But once the chest wall is closed, I re-
move 1000 mL of air to balance the mediastinum. I do not think,
however, that the method used to handle the pneumonectomy
space in the acute setting has much to do with long-term results
of pulmonary function.
Dr Nasser Altorki (New York, NY). It’s easy to understand the
changes in FEV1 being 33%. You know, you get adjustments in the
small airway mechanics and the chest wall mechanics. What I
don’t understand is your DLCO number, an 18% reduction inThe Journal of Thoracic and Cthe DLCO. I wonder if you have insight into that. There are a lot
of basic researchers in our institutions who are interested in the
concept of pulmonary regeneration, alveolar regeneration. I’m
not suggesting that is going on, but do you have any insight into it?
Dr Deslauriers. I do not really have an insight as to why the
value of DLCO is higher than it should be for only 1 lung, but
the same observations have been made by other investigators. It
certainly indicates that gas transfer is normal, and perhaps there
is a greater exchange surface available because of hyperinflation
of the remaining lung.
DrAltorki.But you are not going to do that with a fixed number
of alveolar spaces. Something has to happen at the alveolar level,
at the gas exchange level.
Dr Deslauriers. I do not have a specific answer to your ques-
tion.
Dr Altorki. Well, I think what you show is true. I’m intrigued
by the explanation. I think we have to learn more about that.
Dr Deslauriers. Thank you for your comments.ardiovascular Surgery c Volume 141, Number 1 15
